Our Rapid Diagnostics Centre offers fast access to advanced imaging, specialist clinics and on-site testing - helping you get clarity in days, not weeks. Plus, our 24/7 private GP service is here whenever you need urgent advice.
As a charitable hospital, we reinvest in exceptional care, research and innovation - helping us improve healthcare for patients here and far beyond our walls.
Your Patient Hub brings together everything you need to prepare for your visit, understand your care and know what to expect throughout your stay.
14 July 2026
The London Clinic has won a national award from charity Myeloma UK for its outstanding care of patients living with incurable blood cancer.
The haematology team was recently presented with the Myeloma UK Clinical Service Excellence Programme (CSEP) Award in recognition of its outstanding care and dedication to patients with myeloma, an incurable blood cancer which claims the lives of 3,200 people in the UK each year.
Staff were praised for their efforts to improve patients’ quality of life and their eagerness to adapt and listen to their needs.
The accolade, awarded by blood cancer charity Myeloma UK, recognises hospitals’ commitment to raising the bar for treatment and providing compassionate care.
I am incredibly proud and honoured that our Haematology Department received accreditation today. This achievement reflects the commitment, expertise and teamwork of our haematology team and the whole multidisciplinary team. I am so pleased that we received such a high score of 85% – deemed 'Excellent' – which is a truly fantastic accomplishment.Monika Sawicka-Leonenko, Haematology Clinical Nurse Specialist
Myeloma occurs in the bone marrow and currently affects over 35,000 people in the UK. It is especially hard to spot as the symptoms are often vague and dismissed as ageing or other minor conditions.
By the time many patients are diagnosed, their cancer has advanced and they require urgent treatment. This can significantly impact their chances of survival and quality of life.
Myeloma is a relapsing-remitting cancer, meaning that although many patients will experience periods of remission following treatment, the disease will inevitably come back.
Monica Morris, Clinical Practice Programme Manager at Myeloma UK, said the hospital also stood out for its access to new treatments and CAR-T, knowledgeable consultants and impressive patient-centred care.
She added that myeloma is a challenging cancer which keeps coming back and can be difficult to cope with both physically and mentally, so the team were “hugely impressed with the hospital’s efforts to ease patients’ burden and make their treatment that little bit easier.”
What stood out was the patient experience. When they come here, they feel part of a family, with every aspect of the patient journey thought about.Monica Morris, Clinical Practice Programme Manager, Myeloma UK
Around 1 in 2 people with myeloma have to wait more than five months before they get the right diagnosis. While it is incurable, myeloma is treatable in the majority of cases.
She added that myeloma is a challenging cancer which keeps coming back and can be difficult to cope with both physically and mentally, so the team were “hugely impressed with the hospital’s efforts to ease patients’ burden and make their treatment that little bit easier.”
Chief Executive Al Russell said, “Huge congratulations to all our brilliant staff in our haematology department on this Myeloma UK recognition. Truly deserved. Everyone at The London Clinic is very proud of you all and I’d like to say thank you for your commitment and dedication to our patients.”
